A look at the phenomenon of high-priced “me too” drugs and “lifestyle” pharmaceuticals that offer little or no improvement over existing generic medications.
Wednesday, May 21, 2008
Big Pharma, Big Bucks (Part 2)
Subscribe to:
Comment Feed (RSS)
|